TCTR20191030004已完成未知
The Incidence of Urticaria, Angioedema, and Type I Hypersensitivity Reactions with Fibrinolytic Agents in Thailand Using Health Product Vigilance Center Database
Faculty of Pharmacy, Silpakorn University0 个研究点目标入组 284 人开始时间: 2019年10月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 284
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 N/A (No limit) 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •All reports of urticaria, angioedema, or type I hypersensitivity reactions caused due to streptokinase, alteplase, and TNK were enrolled, and any reports described as “unlikely†based on Naranjo probability scale was excluded. Terms specified in the spontaneous reporting system according to the WHO adverse reaction terminology (WHO-ART) were used for identifying the reactions
排除标准
- •No data about important
研究者
相似试验
已完成
不适用
Fibrinolytic-Associated Urticaria, Angioedema, and Type I Hypersensitivity Reactions from Various IndicationsAll fibrinolytic agents either non-fibrin or fibrin specific can cause urticaria,angioedema and type I hypersensitivity reactions owing to their mechanism of actionanaphylaxi hypotension streptokinase tenecteplase tissue plasminogen activatorTCTR20190607003o sponsor11
已完成
2 期
Cold Urticaria Treatment With XolairCold Contact UrticariaNCT01580592Charite University, Berlin, Germany31
尚未招募
不适用
study on itching and swellingCTRI/2022/11/047111sushil kumar singh
已完成
2 期
Urticaria Facticia Treatment With Omalizumab (UFO)Symptomatic DermographismNCT02169115Charite University, Berlin, Germany61
已完成
不适用
The Prevalence of contact Allergies for wound dressings In patients with Diabetic foot ulcers.Contact allergy10001316NL-OMON48136Rijnstate Ziekenhuis139